User profiles for Janette Furuzawa-Carballeda
Janette Furuzawa-CarballedaDepto. Cirugía Experimental, INCMNSZ Verified email at incmnsz.mx Cited by 3099 |
Autoimmune inflammation from the Th17 perspective
J Furuzawa-Carballeda, MI Vargas-Rojas… - Autoimmunity reviews, 2007 - Elsevier
Recent studies demonstrated an IL-17-producer CD4 + T cell subpopulation, termed Th17,
distinct from Th1 and Th2. It represents a different pro-inflammatory Th-cell lineage. This …
distinct from Th1 and Th2. It represents a different pro-inflammatory Th-cell lineage. This …
[HTML][HTML] Adipokine contribution to the pathogenesis of osteoarthritis
…, B Ramos-Avalos, J Furuzawa-Carballeda - Mediators of …, 2017 - hindawi.com
Recent studies have shown that overweight and obesity play an important role in the development
of osteoarthritis (OA). However, joint overload is not the only risk factor in this disease. …
of osteoarthritis (OA). However, joint overload is not the only risk factor in this disease. …
[HTML][HTML] New insights into the pathophysiology of achalasia and implications for future treatment
J Furuzawa-Carballeda, S Torres-Landa… - World journal of …, 2016 - ncbi.nlm.nih.gov
Idiopathic achalasia is an archetype esophageal motor disorder, causing significant impairment
of eating ability and reducing quality of life. The pathophysiological underpinnings of this …
of eating ability and reducing quality of life. The pathophysiological underpinnings of this …
[HTML][HTML] Aguamiel concentrate from Agave salmiana and its extracted saponins attenuated obesity and hepatic steatosis and increased Akkermansia muciniphila in …
…, M Aguilar-López, J Furuzawa-Carballeda… - Scientific reports, 2016 - nature.com
Obesity and its comorbidities are a severe public health problem worldwide. The use of
bioactive compounds found in some foods has been demonstrated to ameliorate the metabolic …
bioactive compounds found in some foods has been demonstrated to ameliorate the metabolic …
Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease
G Fonseca-Camarillo, J Furuzawa-Carballeda… - Cytokine, 2015 - Elsevier
The aim of the study was to characterize and to quantify peripheral and tissue. IL-35— and
IL-37—producing cells in Inflammatory Bowel Disease (IBD) patients. We studied a total of 38 …
IL-37—producing cells in Inflammatory Bowel Disease (IBD) patients. We studied a total of 38 …
[HTML][HTML] Differential expression of IL-36 family members and IL-38 by immune and nonimmune cells in patients with active inflammatory bowel disease
…, J Furuzawa-Carballeda… - BioMed research …, 2018 - hindawi.com
IL-1 family includes IL-38 (IL-1F10) and the subfamily of IL-36 and is the central mediators
of inflammatory diseases, including pustular psoriasis, atopic dermatitis, rheumatoid arthritis, …
of inflammatory diseases, including pustular psoriasis, atopic dermatitis, rheumatoid arthritis, …
Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study
TS Rodríguez-Reyna, J Furuzawa-Carballeda… - Rheumatology …, 2012 - Springer
Systemic Sclerosis (SSc) is an autoimmune disease characterized by fibrosis and
vasculopathy. A key feature is the presence of T cells in inflammatory lesions. To establish the …
vasculopathy. A key feature is the presence of T cells in inflammatory lesions. To establish the …
[HTML][HTML] Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study
J Furuzawa-Carballeda, G Hernández-Molina… - Arthritis research & …, 2013 - Springer
Introduction IL-10--producing B cells, Foxp3-expressing T cells (Tregs) and the IDO-expressing
dendritic cells (pDC) are able to modulate inflammatory processes, to induce …
dendritic cells (pDC) are able to modulate inflammatory processes, to induce …
Dor vs Toupet fundoplication after laparoscopic Heller myotomy: long-term randomized controlled trial evaluated by high-resolution manometry
…, E Coss-Adame, J Furuzawa-Carballeda… - Journal of …, 2018 - Springer
Background Laparoscopic Heller myotomy (LHM) with partial fundoplication is an effective
treatment for achalasia. However, the type of fundoplication is still a subject of debate. Aim …
treatment for achalasia. However, the type of fundoplication is still a subject of debate. Aim …
Autoimmune comorbidity in achalasia patients
…, J Furuzawa‐Carballeda… - Journal of …, 2018 - Wiley Online Library
Background and Aim Idiopathic achalasia is a rare esophageal motor disorder. The disease
state manifests local and systemic inflammation, and it appears that an autoimmune …
state manifests local and systemic inflammation, and it appears that an autoimmune …